Larimar Therapeutics, Inc.

LRMR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.98+4.19%

2026-08-03

Financials

Valuation Metrics

Larimar Therapeutics, Inc.'s Market Cap is $413M. At end of 2025 it was $325M. Ranked #2876 of 3,112 in US market (top 92%), #1269 of 1,445 on NASDAQ (top 88%), #230 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 86%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$413M	US#2,876/3,112 Sec#230/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-166M	US—/3,112 Sec—/269
Total Assets	$209M	US#2,973/3,112 Sec#248/269
Net Assets	$158M	US#2,802/3,112 Sec#212/269
Value
P/B	2.62x	US#1,518/3,112 Sec#74/269
FCF Yield	-31.76%	US—/3,112 Sec—/269
Profitability
ROE	-105.04%	US#2,854/3,112 Sec#222/269
ROA	-79.61%	US#3,031/3,112 Sec#255/269
Financial Health
Debt Ratio	31.94%	US#358/3,112 Sec#109/269
Total Debt	$4M	US#2,873/3,112 Sec#223/269
FCF	$-131M	US#2,649/3,112 Sec#176/269
Cash	$178M	US#1,808/3,112 Sec#124/269
Current Ratio	4.29x	US#559/3,112 Sec#161/269
Performance
1Y Return	15.70%	US#1,459/3,112 Sec#164/269
1M Return	22.09%	US#112/3,112 Sec#7/269
From 52W High	-38.01%	US#2,469/3,112 Sec#192/269
1Y MDD	-48.74%	US#2,362/3,112 Sec#182/269
Trading
Volume	785,056 shares	US#1,701/3,112 Sec#162/269
Trading Value	$3M	US#2,812/3,112 Sec#233/269
Per Share
EPS	$-1.94	US—/3,112 Sec—/269
BPS	$0.92	US#2,631/3,112 Sec#204/269